Professor Dario Neri, co-founder of Philogen, shares insights on drug trials, cancer research, and the pharmaceutical industry. From conflicting medical information to drug approval challenges, he delves into the complexities of drug development. The conversation also covers the landscape of cancer treatment companies and the balance between collaboration and competition in the industry.